top of page

Presentations

2011 to 2015

2011

Ikeda T, Abd El Galil KH, Tokunaga K, Maeda K, Sata T, Sakaguchi N, Heidmann T and Koito A. Intrinsic Restriction Activity by APOBEC1 against the Mobility of Autonomous Retrotransposons. Keystone Symposia. Whistler, Canada (Mar 20-25, 2011).

Ikeda T and Koito A. Identification of the functional region required for anti-HIV-1 activity of APOBEC1. Cold Spring Harbor Laboratory Meeting, Retroviruses. Cold Spring Harbor, New York, USA (May 23-28, 2011).

Ikeda T and Koito A. Identification of the functional region required for anti-HIV-1 activity of APOBEC1. Summer Retrovirus Conference in 2011 (SRC2011). Yamanashi, Japan (Jul 28-30, 2011).

Ikeda T and Koito A. Identification of the functional region required for anti-HIV-1 activity of APOBEC1. International Union of Microbiological Societies 2011 Congress, international Congress of Virology. Sapporo Convention Center, Sapporo, Japan (Sep 11-16, 2011).

Ikeda T and Koito A. Identification of the functional region required for anti-HIV-1 activity of APOBEC1. The 25th Annual Meeting of the Japanese Society for AIDS Research. Tokyo, Japan (Nov 30-Dec 2, 2011).

2012

Ikeda T and Koito A. APOBEC1 studies demonstrate the importance of a C-terminal region in HIV-1 restriction. Cold Spring Harbor Laboratory Meeting, Retroviruses. Cold Spring Harbor, New York, USA (May 21-26, 2012).

Ikeda T, Fukuda K and Koito A. Analysis of anti-retroviral and retroelement activity by opossum APOBEC1. The 60th Annual Meeting of the Japanese Society for Virology. Osaka, Japan (Nov 13-15, 2012).

2013

Ikeda T, Albin JS and Harris RS. Vif-deleted HIV-1 can evolve to replicate in a T cell line expressing full repertoire of restrictive APOBEC3 proteins. 2013 Institute for Molecular Virology Annunal Symposium. University of Minnesota, Minnesota, USA (May 8, 2013).

2014

Ikeda T, Albin JS, Symeonides M, Thali M and Harris RS. Env Substitutions Can Protect Vif-null HIV-1 from Mutagenesis by APOBEC3G. 2014 Institute for Molecular Virology Annunal Symposium. University of Minnesota, Minnesota, USA (May 12, 2014).

Ikeda T, Refsland EW, Hultquist JF, Luengas EM, Emerman M and Harris RS. Natural Variation in HIV-1 Vif Determines the Ability of Endogenous Levels of the Polymorphic APOBEC3H Protein to Suppress Virus Replication in Primary T Cells. Cold Spring Harbor Laboratory Meeting, Retroviruses. Cold Spring Harbor, New York, USA. (May 19-24, 2014).

Ikeda T, Albin JS, Mundt D, Symeonides M, Thali M and Harris RS. Env substitutions Can Protect Vif-null HIV-1 from APOBEC3G Deamination. 2nd Joint UMN-UW Virology Training Grant Symposium. University of Wisconsin-La Crosse, Wisconsin. (Oct 10, 2014).

2015

Ikeda T, Albin JS, Symeonides M, Mundt D, Thali M and Harris RS. Vif-null HIV-1 Can Avoid APOBEC3G Mutagenesis by an Env-Dependent Mechanism. 2015 Institute for Molecular Virology Annunal Symposium. University of Minnesota, Minnesota, USA (May 11, 2015).

Ikeda T, Albin JS, Mundt D, Symeonides M, Thali M and Harris RS. Vif-null HIV-1 Can Avoid APOBEC3G Mutagenesis by an Env-Dependent Mechanism. Cold Spring Harbor Laboratory Meeting, Retroviruses. Cold Spring Harbor, New York, USA. (May 18-23, 2015). Talk.

Ikeda T, Albin JS, Mundt D, Symeonides M, Thali M and Harris RS. Env Substitutions Enhance Gag-Pol Packaging and Protect from APOBEC3G Restriction. 3rd Joint UMN-UW Virology Training Grant Symposium. University of Wisconsin-La Crosse, Wisconsin. (Sep 25, 2015)

2011 to 2015: ニュース
bottom of page